• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CRON

CRON

Cronos Group Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericCA

USD2.71

-0.02 (-0.73%)

Rating:B

Company Profile

CEO

Michael Ryan Gorenstein

IPO Date

2018-02-27

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

CA

Market Metrics

Open

$2.71

Prev. Close

$2.73

Day Low

$2.65

Day High

$2.74

52W Low

$1.84

52W High

$3.43

Market Cap

$1.01B

Volume

1.95M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

27.1%

Avg Negative

2.3%

Avg Neutral

70.4%

News Feed

2 Canadian Marijuana Stocks To Watch At The End Of August

MarijuanaStocks·8/31/2021·↑ positive

Best Cannabis Stocks To Invest In Right Now? 2 For Your List For September 2021

MarijuanaStocks·8/27/2021·↑ positive

Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

GlobeNewsWire·8/23/2021·↑ positive

Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference

GlobeNewsWire·8/9/2021·↑ positive

Cronos Group Inc. (CRON) CEO Kurt Schmidt on Q3 2021 Results - Earnings Call Transcript

Seeking Alpha·8/6/2021·↓ negative

Cronos Group CBD Co. Shares Slightly Down After Announcing Q2 2021 Results And New CFO Appointment

Benzinga·8/6/2021·↑ positive

Cronos Group Appoints Bob Madore as Chief Financial Officer

GlobeNewsWire·8/6/2021·↓ negative

Cronos Group Reports 2021 Second Quarter Results

GlobeNewsWire·8/6/2021·↑ positive

Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021

GlobeNewsWire·7/23/2021·↑ positive

The Best Pot Stocks to Buy on the Dip After U.S. Legalization Failed

InvestorPlace·7/20/2021·↑ positive